Disclosure: This is not a recommendation to buy a security. Always get professional financial advice. Investing in biotech stocks is risky with the potential for large non-recoverable losses.
InmuneBio ($INMB)
Everyone is talking about Jon Kulok’s InmuneBio write up. So we had to get him on YWR.
In Part 1 of the video Jon explains water soluble TNF’s and why ImmuneBio could eventually be a $2bn market cap company.
In Part 2 we speak to CEO RJ Tesi on the Stage 2 Trial and why ImmuneBio is on the path to curing some forms of Alzheimers.
Enjoy,
Erik
Share this post